FOLIGNO, NADIA EDVIGE
 Distribuzione geografica
Continente #
AS - Asia 72
NA - Nord America 65
EU - Europa 63
SA - Sud America 6
AF - Africa 2
Totale 208
Nazione #
US - Stati Uniti d'America 62
IT - Italia 33
CN - Cina 28
SG - Singapore 23
DE - Germania 6
NL - Olanda 6
BR - Brasile 5
GB - Regno Unito 5
HK - Hong Kong 5
IN - India 4
VN - Vietnam 4
CA - Canada 3
FR - Francia 3
RU - Federazione Russa 3
IL - Israele 2
JP - Giappone 2
PL - Polonia 2
SE - Svezia 2
TR - Turchia 2
BE - Belgio 1
EC - Ecuador 1
ES - Italia 1
IQ - Iraq 1
MT - Malta 1
SN - Senegal 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 208
Città #
Ashburn 19
Singapore 13
Beijing 6
Los Angeles 6
Milan 6
Rome 6
Hong Kong 5
Shanghai 5
Dallas 3
Hefei 3
New York 3
Grassobbio 2
Hanoi 2
London 2
Montreal 2
Mumbai 2
Nuremberg 2
Orem 2
Poplar 2
Sesto San Giovanni 2
Warsaw 2
Adana 1
Amsterdam 1
Angatuba 1
Augusta 1
Bismarck 1
Brooklyn 1
Brussels 1
Bunkyo-ku 1
Charleston 1
Chengdu 1
Chennai 1
Chicago 1
Cologne 1
Curitiba 1
Dakar 1
Denver 1
Duque de Caxias 1
Falkenstein 1
Groningen 1
Hangzhou 1
Ho Chi Minh City 1
Houston 1
Hải Dương 1
Jandira 1
Johannesburg 1
Mahendragarh 1
Marsaskala 1
Marília 1
Munich 1
Oak Creek 1
Paris 1
Pavia 1
Pescara 1
Phoenix 1
Rishon LeTsiyyon 1
Shantou 1
Taiyuan 1
Tampa 1
Tashkent 1
Tokyo 1
Toronto 1
Tulcán 1
Weitang 1
Xingtai 1
Totale 139
Nome #
Different Efficacy of Burosumab on Physical Performance and Serum Phosphate in Adult Patients with X-Linked Hyphophosphatemic Rickets during the First Six-Month of Treatment 87
New year, new variant: Drawing lessons from frail elderly people 53
Efficacy of burosumab in healing a long-standing femoral fracture in an adult patient with X-linked hypophosphatemic rickets 51
New year, new variant: drawing lessons from frail elderly people 24
Totale 215
Categoria #
all - tutte 1.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 1 2 0 0 1 0 0 1
2023/202420 2 1 3 5 0 0 0 0 2 0 5 2
2024/202567 7 1 13 3 2 9 12 9 4 1 2 4
2025/2026123 17 11 8 44 42 1 0 0 0 0 0 0
Totale 215